RecruitingNCT07713056

Clinical Characteristics of Pigmentary Glaucoma and Efficacy Analysis of Ab-interno 120° Trabeculotomy

Clinical Characteristics of Pigmentary Glaucoma and Efficacy Analysis of Ab-interno 120° Trabeculotomy: A Case Series Study

Sponsor

Zhongnan Hospital

Enrollment

11 participants

Start Date

Apr 1, 2026

Study Type

OBSERVATIONAL

Conditions

Pigmentary Glaucoma

Summary

This study aims to investigate the clinical characteristics of pigmentary glaucoma and evaluate the efficacy and safety of ab-interno 120° trabeculotomy during the 6-month postoperative follow-up period.

Eligibility

Min Age: 16 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Ab-interno 120° Trabeculotomy for people with pigmentary glaucoma. The study is currently recruiting participants at 1 location. People eligible for this study include aged 16 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAb-interno 120° Trabeculotomy

A minimally invasive glaucoma surgery (MIGS) procedure performed via an ab interno approach, involving a 120-degree incision of the trabecular meshwork to improve aqueous humor outflow.

Locations(1)

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07713056

Related Trials

Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options

NCT073032571 location

Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

NCT072282211 location